78501419 - TAGNOLOGIES

Information

  • Trademark
  • 78501419
  • Serial Number
    78501419
  • Filing Date
    October 18, 2004
    20 years ago
  • Transaction Date
    July 23, 2011
    13 years ago
  • Status Date
    January 23, 2007
    17 years ago
  • Location Date
    July 23, 2006
    18 years ago
  • Status Code
    601
  • Current Location
    TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    CHOINIERE, MONIQUE
  • Attorney Docket Number
    005155.00014
    Attorney Name
    Helen Hill Minsker
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4000
Mark Identification
TAGNOLOGIES
Case File Statements
  • GS0011: Chemicals used in industry and science, in particular proteins including fusion proteins, in particular streptavidin and streptavidin muteins, antibodies, kinases, phosphatases, proteases, G proteins and G protein coupled receptors, peptides, in particular affinity peptides, peptides mediating cell membrane permeation as well as peptides mediating cell and tissue specifity, nucleic acids, in particular nucleic acids encoding the aforementioned proteins and peptides, vectors, in particular expression vectors as well as chemically synthesized oligonucleotides and nucleic acids, especially DNA, RNA, LNA, namely locked nucleic acid and PNA, namely peptide nucleic acid, oligonucleotides, oligonucleotides optionally furnished with an attached dye, viruses or viroids, cells, in particular body cells and cells of the immune system of mammals including human cells, combination products of proteins and/or peptides and other proteins or peptides or nucleic acids or viruses or viroids or cells, kits for analysis comprised of resin for chromatographic separation of proteins and polypeptides and buffers for purification of proteins, kits for analysis comprised of a purification column packed with resin for chromatographic separation of proteins and polypeptides, and buffers for purification of proteins and polypeptides, kits for analysis comprised of a purification column packed with resin for chromatographic separation of protein and polypeptides, buffers for purification of proteins and polypeptides, and reagent for Western Blot detection of proteins, kits for analysis comprised of a purification column packed with resin for chromatographic separation of proteins and polypeptides, buffers for purification of proteins and polypeptides, reagent for Western Blot detection of proteins, an expression vector for recombinant production of proteins and polypeptides and reagent for inducing recombinant gene expression , and test agents, produced chemically and/or by means of gene technology for use in industry and science for purification and/or labeling and/or funcitionalization and/or detection and/or immobilization of nucleic acids, peptides and proteins including fusion proteins, viruses, viroids and/or cells, in particular of body cells and cells of the immune system of mammals including human cells, diagnostics, except for medical purposes
  • GS0051: Pharmaceutical preparations for the treatment of immunological diseases, auto-immune diseases, viral diseases and cancer, and veterinary preparations, in particular nucleic acids, peptides and proteins including fusion proteins, viruses or viroids, cells, in particular body cells and cells of the immune system of mammals including human cells, furthermore chemically and/or by means of gene technology produced combination products of proteins and/or peptides and other proteins or peptides or nucleic acids or viruses or viroids or cells, diagnostics for medical purposes as well as antisera and vaccines
  • GS0421: Research in science and industry in the areas of biochemistry, diagnostics and pharmaceuticals, services of an analytical, biochemical or pharmaceutical laboratory, in particular synthesis and purification of peptides and proteins, purification of viruses and viroids, cultivation and purification of cells, in particular of body cells and cells of the immune system of mammals including human cells, synthesis of nucleic acids and oligonucleotides, synthesis of vectors, in particular of expression vectors, preparation of combination products of proteins and/or peptides and other proteins or peptides or nucleic acids or viruses or viroids or cells by chemical means and/or means of gene technology, synthesis of active pharmaceutical agents as well as isolation of antisera and vaccines
  • PM0000: TAG TECHNOLOGIES
Case File Event Statements
  • 1/23/2007 - 17 years ago
    16 - ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Type: MAB1
  • 1/23/2007 - 17 years ago
    15 - ABANDONMENT - EXPRESS MAILED Type: ABN1
  • 1/23/2007 - 17 years ago
    14 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 10/6/2006 - 18 years ago
    13 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/23/2006 - 18 years ago
    12 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 7/23/2006 - 18 years ago
    11 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 6/16/2006 - 18 years ago
    10 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 12/14/2005 - 19 years ago
    9 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/14/2005 - 19 years ago
    8 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/5/2005 - 19 years ago
    7 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 11/17/2005 - 19 years ago
    6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/17/2005 - 19 years ago
    5 - PAPER RECEIVED Type: MAIL
  • 5/25/2005 - 19 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/25/2005 - 19 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/19/2005 - 19 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/26/2004 - 20 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP